Latest News

Avantium NV bags money for demo plant

© Avantium NV


by tg

Green chemistry company Avantium NV has secured a €7.5m funding from the National Programme Groningen to support the construction of a 5 kilotonnes FDCA plant.

The new grant is part of a €30m financing mix that Avantium and the Groningen consortium announced this January.

FDCA is the key building block for PEF (polyethylene furanoate), a plant-based, fully recyclable plastic material that outperforms today’s standard PET with regards to environmental footprint and performance. The FDCA flagship plant to be built in Delfzijl is planned to start up in 2023. This will provide around 60 jobs in the region. 

Avantium and the Groningen consortium already entered into an agreement earlier this year relating to the conditional financing mix of €30m for the construction of the FDCA plant.  The Groningen consortium comprises of the Province of Groningen, Groningen Seaports and regional investment funds NOM (Investment and Development Agency for the Northern Netherlands), FondsNieuweDoen, Investeringsfonds Groningen and Groeifonds.

Henkel buys FDCA from Avantium NV

From next year, Henkel will buy FDCA to bring environmentally friendly high-performance polyurethane adhesives for electronic applications to market....

Upping sustainability in pharma packaging

From glass vials, over cardboard applications, and biodegradable containers, at the PHARMAPACK Europe 2023 taking place on February 1st and 2nd in...

German HTGF IV fund closes at €493m

Alongside the Federal Ministry of Economics and Climate Protection (BMWK) and KfW Capital, 45 private investors (companies) participated in HTGF IV...

Pfizer-Seagen: Acquisition in the works

As announced earlier this week, Pfizer Inc. plans to purchase Seagen for US$43bn. The Boards of Directors of both companies approved the transaction...

New partnerships push InDevR for Series B financing

Investments into InDevR, Inc. came from New York-based Adjuvant Capital ($4m) and French bioMèrieux SA ($5m), which will enable the commercial...

Upscaling AAV gene therapy

Mid-March marks the start of the collaboration of Remedium Bio Inc. and Biovial Oy on an AAV gene therapy for osteoarthritis. Rheumatology and...

Neurodegenerative disorders are being fought with €28m

The Danish biotech Teitur Trophics ApS, aiming to treat chronic neurological disorders, has completed a €28m Series A funding. With the money, Teitur...